SEATTLE GENETICS INC (71) | Collaboration Agreements (3)
- Collaboration and License Agreement dated January 7, 2007 between (Filed With SEC on February 9, 2022)
- License and Collaboration Agreement relating to ladiratuzumab vedotin dated September 13, 2020 between Seagen Inc. (f/k/a Seattle Genetics, Inc.) and Merck Sharp & Dohme Corp (Filed With SEC on October 30, 2020)
- Collaboration Agreement between Seattle Genetics, Inc. and Millennium Pharmaceuticals, Inc. (a wholly-owned subsidiary of Takeda Pharmaceutical Company Limited) dated December 14,... (Filed With SEC on February 6, 2020)
